Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Andrew D. Campbell, MD
Comprehensive Sickle Cell Disease Program
Children's National Health System
111 Michigan Avenue, NW
Washington, DC, United States
Dr. Campbell’s distinguished training and career path began at Morehouse College. He continued medical school at Case Western Reserve University and completed post graduate training at Massachusetts General Hospital (Harvard) and Lurie Children’s Hospital (Northwestern University). Prior to joining Children’s National, he was Director of the Comprehensive Sickle Cell Center at the University of Michigan, a position he held since 2005. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships, and renal complications.
Areas of Interest:
Pulmonary Hypertension in sickle cell disease
Phenotype/genotype Studies within twin and siblings with sickle cell disease
Morbidity and mortality in transitioning sickle cell patients
Fetal hemoglobin switching within sickle cell trangenic mice
A Patient Advocate’s Take on Sickle Cell Disease: The Pain and the PromiseSeptember is National Sickle Cell Awaren...
Factors influencing utilization of hospital services by adult sickle cell disease patients: a systematic reviewBACKGROUND: Painful vaso-occlusive crisi...
Steven Ambrusko, MD, MSDr. Ambrusko is a pediatric hematologist...
Health Care Utilization Trajectories and Associated Factors for Transitioning Adolescents/Young Adults with Sickle C...Limited research had explored health car...
Tiffany Bell, MSWTiffany Bell completed her MSW in 2015 f...
New York State Sickle Cell Advocacy Network (NYSSCAN)New York State Sickle Cell Advocacy Netw...
Hospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...